Novavax Inc. and the Florida Cancer Specialists & Research Institute LLC have added in-house talent after separately facing legal scrutiny for actions the companies’ leaders took.
Novavax, currently working on a vaccine for Covid-19 and coping with claims that its leaders lined their pockets while the company embarked on the effort, announced Monday the addition of chief compliance officer Troy Morgan. He will join the biotechnology company April 19 and report to chief legal officer John Herrmann III.
FCS, a Fort Myers, Fla.-based oncology provider, disclosed a week earlier its addition of chief legal officer Nancy Ardell. She was ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.